Connect with us

Hi, what are you looking for?

Sunday, Apr 20, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "NeoLumina Bioscience"

Filament Health gives NeoLumina Bioscience license to psilocybin drug for eating disorders

Filament Health gives NeoLumina Bioscience license to psilocybin drug for eating disorders

Psychedelics

NeoLumina Bioscience to develop Filament Health patented psilocybin as eating disorders treatment

Filament will be licensing NeoLumina with its PEX010 drug and associated IP for commercial and clinical development

Rowan DunneJuly 3, 2023

More Posts